Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Belite Bio (NASDAQ:BLTE) Stock, Analyst Ratings, Price Targets, Forecasts
Belite Bio Inc has a consensus price target of $73 based on the ratings of 5 analysts. The high is $110 issued by Maxim Group on November 15, 2024. The low is $25 issued by SVB Leerink on July 26, 2023. The 3 most-recent analyst ratings were released by Maxim Group, HC Wainwright & Co., and HC Wainwright & Co. on November 15, 2024, November 13, 2024, and September 12, 2024, respectively. With an average price target of $90 between Maxim Group, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 42.93% upside for Belite Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
HC Wainwright & Co.
Benchmark
SVB Leerink
1calculated from analyst ratings
Analyst Ratings for Belite Bio
Data brought to you by Benzinga APIs
FAQ
What is the target price for Belite Bio (BLTE) stock?
The latest price target for Belite Bio (NASDAQ:BLTE) was reported by Maxim Group on November 15, 2024. The analyst firm set a price target for $110.00 expecting BLTE to rise to within 12 months (a possible 74.69% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Belite Bio (BLTE)?
The latest analyst rating for Belite Bio (NASDAQ:BLTE) was provided by Maxim Group, and Belite Bio maintained their buy rating.
When was the last upgrade for Belite Bio (BLTE)?
There is no last upgrade for Belite Bio
When was the last downgrade for Belite Bio (BLTE)?
There is no last downgrade for Belite Bio.
When is the next analyst rating going to be posted or updated for Belite Bio (BLTE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Belite Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Belite Bio was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.
Is the Analyst Rating Belite Bio (BLTE) correct?
While ratings are subjective and will change, the latest Belite Bio (BLTE) rating was a maintained with a price target of $60.00 to $110.00. The current price Belite Bio (BLTE) is trading at is $62.97, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.